Tower Research Capital (TRC)’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,794
Closed -$99.4K 5666
2025
Q4
$99.4K Buy
5,794
+5,294
+1,059% +$53.8K ﹤0.01% 1949
2025
Q3
$2.63K Sell
500
-9,495
-95% -$42.6K ﹤0.01% 4604
2025
Q2
$41.8K Buy
9,995
+9,895
+9,895% +$62.1K ﹤0.01% 3122
2025
Q1
$1.4K Sell
100
-1,473
-94% -$25.8K ﹤0.01% 4713
2024
Q4
$44.2K Buy
+1,573
New +$135K ﹤0.01% 2630

Other funds holding MSTZ

Tower Research Capital (TRC)'s MSTZ Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 5,794 shares — an estimated $99.4K sold.

Tower Research Capital (TRC) first reported a position in MSTZ in Q4 2024 and held it in 5 quarters. The position peaked at $99.4K in Q4 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 5,794 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $99.4K.
  • Tower Research Capital (TRC) first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q4 2024 and held it in 5 quarters.
  • Tower Research Capital (TRC)'s T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $99.4K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.